Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (9)
- Doctoral Thesis (1)
Keywords
- Crohn's disease (2)
- ileocecal resection (2)
- inflammatory bowel disease (2)
- microbial spectrum (2)
- surgical therapy (2)
- Caco2 cells (1)
- Colorectal liver metastases (1)
- Crohn’s Disease (1)
- Crohn’s disease (1)
- Cushing (1)
- Kolorektale Lebermetastasen (1)
- Kono-S anastomosis (1)
- Lebermetastasen (1)
- MTL30 (1)
- adrenal surgery (1)
- anastomotic leakage (1)
- anorectal abscess (1)
- antibiotic resistance (1)
- colon resection (1)
- complication (1)
- cost-effectiveness (1)
- enteroids (1)
- epithelial cells (1)
- fistulizing Crohn’s Disease (1)
- gut barrier (1)
- inflammation (1)
- inflammatory cell model (1)
- intestinal epithelial barrier (1)
- intestinal organoids (1)
- intraabdominal abscess (1)
- left hemicolectomy (1)
- microbiota (1)
- mucosal healing (MH) (1)
- penetrating ileitis (1)
- perianal fistulas (1)
- postoperative inflammation (1)
- robotic surgery (1)
- surgery (1)
- surgical outcome (1)
- terminal ileitis (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (10)
- Comprehensive Cancer Center Mainfranken (2)
- Medizinische Klinik und Poliklinik II (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Kinderklinik und Poliklinik (1)
- Medizinische Klinik und Poliklinik I (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 101042738 (1)
Despite the increasing incidence and prevalence of Crohn’s Disease (CD), no curative options exist and treatment remains complex. While therapy has mainly focused on medical approaches in the past, growing evidence reveals that in cases of limited inflammation, surgery can suffice as an alternative primary treatment. We retrospectively assessed the disease course and outcomes of 103 patients with terminal Ileitis who underwent primary surgery (n = 29) or received primary medical treatment followed by surgery (n = 74). Primary endpoint was the need for immunosuppressive medication after surgical treatment (ileocecal resection, ICR) during a two-years follow-up. Rates for laparoscopic ICR were enhanced in case of early surgery, but no differences were seen for postoperative complications. In case of immunosuppressive medication, patients with ICR at an early state of disease needed significantly less anti-inflammatory medication during the two-year postoperative follow-up compared to patients who were primarily treated medically. Furthermore, in a subgroup analysis for patients with localized ileocecal disease manifestation, early surgery consistently resulted in a decreased amount of medical therapy postoperatively. In conclusion primary ICR is safe and effective in patients with limited CD, and the need for immunosuppressive medication during the postoperative follow-up is low compared to patients receiving surgery at a later stage of disease.